Former Hilbert mansion draws local interest in auction
Sealed-bid auction attracts a half-dozen bids from interested owners that are “more centrally located than you might think,”
said the listing agent.
Health Care & Life Sciences
Articles
Some states suing feds also claim health subsidies
An administration official said Tuesday that seven states, including Indiana, suing the federal government are among 16 already
approved for subsidies to help with the health care costs of early retirees.
Indiana report shows drop in medical errors
The most common error in the 2009 report was a foreign object such as a sponge left in a patient after surgery.
Health insurer cash shifts to favor Republicans before election
Health insurers led by WellPoint Inc. are backing Republicans with campaign donations by an 8-to-1 margin, favoring the party
that’s promised to repeal President Barack Obama’s health-care overhaul if it wins back Congress.
Lilly wins further delay in sales of Strattera copies
Strattera generated U.S. sales of $445.6 million last year, and each day that Lilly can fend off generic competition would
translate into an average $1.22 million in sales.
iSalus sees business boom as docs chase stimulus cash
The company is seeing a rush of new sales for its Web-based electronic medical record system from doctors, who all stand to
receive bonus payments from the federal stimulus act for computerizing their patient records.
Endocyte’s $86M IPO plan a boon for Indiana, investors
Venture capitalists in Indiana and nationally have thrown money at the company with abandon. Local investors include CID Capital,
Clarian Health Ventures and the Indiana Future Fund.
Dean named for planned osteopathic school at Marian
Marian University in Indianapolis has named the founding dean of an Atlanta-area medical school to head up the school for
osteopathic doctors it plans to open in 2012.
California OKs Anthem rate hike after controversy
The California Department of Insurance said Wednesday it approved a rate increase averaging about 14 percent for Anthem Blue
Cross customers. The department also OK’d a nearly 19-percent increase for Blue Shield of California.
Estimate puts Indiana health overhaul costs at $3.1B
Family and Social Services Administration Secretary Anne Murphy and acting Insurance Commissioner Stephen Robertson have sent
Gov. Mitch Daniels a letter that now estimates the overhaul will cost Indiana $235 million more than the previous estimate
in May.
Diabetes research pioneer Kirtley dies at 96
Diabetics who control their disease with pills instead of frequent insulin injections can thank Dr. William R. Kirtley, a
groundbreaking Eli Lilly researcher.
A half-century later, Indiana Landmarks returns to roots
Bankrolled by yet another multimillionaire, the historic preservation group is preparing to move into a new headquarters
in Old Centrum, a former church now undergoing a big renovation.
VA hospital, health-info exchange enter pilot project
The Roudebush Veterans Affairs Medical Center and the Indiana Health Information Exchange are going to work to make
their medical record systems talk to each other in a pilot project spearheaded by the U.S. Department of Veterans Affairs.
Lilly woes take notch out of debt rating
Even with debt levels at Eli Lilly and Co. at paltry lows, a string of bad news finally forced Standard & Poor’s
to lower
its rating on the company’s senior unsecured debt. But the New York-based agency said it believes the Indianapolis-based
drugmaker will eventually break its string of bad luck on developing new products.
Health costs surge despite weak inflation
Ben Bernanke may be worried about deflation in the economy, but there’s certainly no chance of it in health care and
insurance. Employers’ health plan premiums surged another 8 percent this year, according to results from a massive survey
by Indianapolis-based United Benefit Advisors.
Indiana gets $1M to monitor health insurance premiums
The state will use the money to review proposed premium increases. It also will look at best practices in other states to
identify areas where it can strengthen health insurance laws and rules.
St. Vincent seeks growth in transplants
St. Vincent Health is moving aggressively to expand its transplant program in a direct challenge to Clarian Health’s dominance
in the field. The Indianapolis-based hospital system filed in July for permission to conduct pancreas transplants. And down
the road, it’s eyeing liver and maybe even lung transplants.
Pearl IRB first firm in state to pre-screen clinical drug trials
Two former Eli Lilly and Co. employees launched the firm that promises to attract more clinical trial business to the state.
Lilly gains panel’s backing to expand Cymbalta use
Outside advisers to the Food and Drug Administration voted 8-6 Thursday in favor of a broader use of Cymbalta on the basis
of studies in lower back pain and osteoarthritis of the knee.
Lilly wins temporary ban on sales of Strattera copies
The invalidation of Lilly’s Strattera patent opened the door for as many as 10 companies to sell generic versions of the drug,
which generated U.S. sales of $445.6 million last year as a treatment for attention deficit hyperactivity disorder.